Development of a new drug requires much research, a long development time and also coordinated team efforts of a large group of researchers in various fields. Instead of searching for new drugs using a random, hit-or-miss approach, the development of superior drug delivery systems (DDS), which enhance the therapeutic efficacy of conventional drugs by controlling the release rate and/or targeting to the disease sites, may be an effective approach to improve the efficacy of chemotherapeutic agents.
In the present study, the usefulness of the transdermal route for absorption of antitumor agents was investigated, since the application of transdermal controlled-release medication is one of the most potentially valuable DDS development programs. The effects of vehicles and an absorption enhancer, Azone (laurocapram, 1-dodecylazacycloheptan-2-one, or 1-dodecylhexahydro-2H-azepin-2-one), on the permeability of a model antitumor agent, 5-fluorouracil (5-FU), across the hairless rat skin were measured in vitro and in vivo. Poly(acrylic acid) (Carbopol 934) gels were chosen as a vehicle and compared with a commercial ointment. Preparation of Poly(Acrylic Acid) Gels-CP was dispersed either in water (CP aq gel) , PG (CP pg gel), or 50% PEG 400 i n water (CP peg gel). In addition, 10% NaOH or diisopropanolamine was added to thicken CP aq gel and CP peg gel or CP pg gel, respectively. The concentration of CP was 0 .8% (w/v), and the pH was adjusted to 7.0. 5-FU and Azone were added when required as a solution (or emulsion) in water , PG, or 50% PEG 400 in water. Final concentrations of 5-FU and Azone in gels were 1% and 3-15% , respectively.
Determination of Viscosity of Gels- 
Results
Effect of Azone on the Rheological Properties of Gels and on in Vitro 5-FU Release from Ointment and Gels The rheological properties of CP gels were found to depend on the kind and amount of neutralizing agents and the concentration of CP. In the present study, we adjusted the concentration of CP and pH to 0.8% and pH 7. Figure 3 shows the viscosity versus shear rate 
Discussion
In vitro release of 5-FU from CP aq gel was very fast and no significant effect of the viscosity of gels on the release was found. Since Azone did not promote drug release from the gels, the Azone effect on 5-FU transport across the skin should be caused in the skin. We suggested in the previous papers5) that Azone affects the skin, especially the stratum corneum. However, the mechanism of the skin penetration enhancing effect of Azone is still unknown. Stoughton6a) examined the effect of Azone concentration on the skin permeation of erythromycin and sodium fusidate. The penetration of erythromycin was enhanced by Azone in a monotonic fashion, rising to an apparent plateau at concentrations of Azone above 30-40%. In the case of sodium fusidate, a low concentration of Azone produced a 2-to 3-fold enhancement, but higher concentrations showed less enhancement. Stoughton and McClure6b) also examined the effect of Azone on 5-FU permeation from water and propylene glycol formulations. A maximum effect was observed at 1.8% Azone; higher concentrations (9.0 and 45.0%) were less effective. From these results and the present data, it is clear that the concentration of Azone which is required to produce optimum enhancement varies from one drug and/or formulation to another. Each drug and formulation should be studied over a range of concentrations of Azone in order to optimize skin permeation.
The blood concentration of 5-FU after administration of 5-FU with Azone gel was very high and comparable to that achieved by systemic therapies (i.v. and p.o.) at the same dosage level. In general, the steady-state blood level, Css, after topical application can be estimated by using the following equation; 
where P, Cs and A are the permeability coefficient of the drug across the skin, the solubility of the drug in the formulation and its application area.7) From both equations, P can be written as follows. 
